Effects of stimulant medication on neuropsychological functioning in college students without ADHD.
Open accessAbstract
= 21) completed a no-drug baseline session and two counterbalanced experimental sessions that involved ingesting a placebo capsule or an amphetamine-dextroamphetamine immediate release 10 mg capsule. For each session, participants completed objective and self-report/subjective neuropsychological measures. Results indicated no significant differences across sessions for self-report/subjective measures and most objective measures. Specifically, for two outcomes on an objective measure (i.e., continuous performance task-identical pairs), performance improved in either the stimulant and placebo conditions compared to baseline or only the placebo condition compared to baseline. Taken together, the results of this study provide further evidence that stimulant medication does not confer neuropsychological improvement in students without ADHD, and perceived improvements may be better attributed to placebo, rather than pharmacological effects of a stimulant medication for this group. This information can inform ongoing efforts to discourage nonmedical prescription stimulant among college students without ADHD. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
AI snapshot
Written from the paper’s full text.
TL;DR
In a within-subject, double-blind study of 21 college students without ADHD, amphetamine–dextroamphetamine immediate release 10 mg did not improve neuropsychological functioning relative to placebo or baseline on most objective and all self-report/subjective measures. The few objective improvements occurred in placebo or both capsule conditions compared with baseline, suggesting placebo or practice effects rather than stimulant-specific enhancement.
Key findings
- No significant main effect of time for most objective outcomes: CPT-IP response time variability (F = 0.76, p = 0.47, ηp² = 0.04), CPT-IP omission errors (F = 2.28, p = 0.13, ηp² = 0.10), Spatial Span Forward (F = 0.44, p = 0.64, ηp² = 0.02), and Spatial Span Backward (F = 1.00, p = 0.37, ηp² = 0.05).
- CPT-IP d-prime showed a significant time effect (F = 11.38, p < 0.01, ηp² = 0.36), with both amphetamine–dextroamphetamine and placebo improved versus baseline and not different from each other; CPT-IP commission errors also showed a time effect (F = 5.51, p = 0.01, ηp² = 0.22), with placebo improved versus baseline. Post hoc analyses controlling for capsule randomization made both effects non-significant (d-prime: F = 0.12, p = 0.89, ηp² = 0.01; commission errors: F = 0.61, p = 0.55, ηp² = 0.03).
- No significant time effects for self-report/subjective measures: modified DSM-5 ADHD Symptoms Checklist inattention (F = 0.87, p = 0.42, ηp² = 0.04) and hyperactivity/impulsivity (F = 0.01, p = 0.98, ηp² = 0.00), or BDEFS-SF-M total score (F = 1.16, p = 0.31, ηp² = 0.06).
- Manipulation check showed no significant difference in belief of receiving amphetamine–dextroamphetamine between stimulant (M = 3.52, SD = 1.94) and placebo (M = 2.38, SD = 1.88) sessions (t = 1.76, p = 0.09). Exploratory analyses found no significant biological sex differences on any outcome after Benjamini-Hochberg correction.
Methods
- Within-subject design: participants (n = 21) completed a no-drug baseline session and two counterbalanced, double-blind experimental sessions involving placebo or amphetamine–dextroamphetamine immediate release 10 mg; cognitive tasks were completed 90 minutes after capsule ingestion.
- Sample: ages 18–25 (M = 20.48, SD = 1.91), 100% cisgender, 52.4% male, 95.2% non-Hispanic, 90.5% White and 9.5% multiracial; all denied lifetime ADHD diagnosis and reported minimal inattention (M = 1.14, SD = 1.49) and hyperactivity/impulsivity (M = 0.67, SD = 0.91) symptoms.
- Measures and analysis: objective CPT-IP, Spatial Span Forward/Backward; self-report modified DSM-5 ADHD Symptoms Checklist and modified Barkley Deficits in Executive Functioning Scale–Short Form; one-way repeated measures ANOVAs across baseline, stimulant, and placebo, pairwise comparisons, post hoc analyses controlling capsule randomization, and exploratory independent-samples t-tests with false discovery rate control.
Limitations
- The paper states that practice effects could explain post-baseline improvements despite post hoc analyses; other objective neuropsychological outcomes were not examined; self-report/subjective measures were completed at least 24 hours after sessions; no ecologically valid academic performance measure was included; only amphetamine–dextroamphetamine IR 10 mg was tested, so results may not apply to other dosages, formulations, or stimulant varieties; meals were not standardized; caffeine was not monitored between sessions; and analyses were powered only for medium or large effects, so small effects may have gone undetected.
- The paper also notes that an adequate sample of men and women is needed to determine whether biological sex differences exist.
- Evident from the text: the sample was small (n = 21) and predominantly White, cisgender, and non-Hispanic, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
12 of 33 cited sources checked · 6 supported · 1 flagged · accuracy not yet measured
- Premisereasoning
Only one prior study (Ilieva et al., 2013) included baseline, stimulant, and placebo conditions.
“Only one study (Ilieva et al., 2013) included baseline, stimulant, and placebo conditions”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Ilieva et al., 2013 source
The Methods (Procedure and materials; page unavailable) describe this paper's study as an online survey of past stimulant use and perceived effects, not a study with baseline, stimulant, and placebo conditions. The Introduction mentions a separate placebo-controlled study by the authors, but our copy does not say that this paper included the three claimed conditions or establish the claim that it was the only such study. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
It is unlikely that minor enhancement effects on objective tasks would translate into improved real-world academic performance.
“Further, although some studies found small enhancement effects on these tasks for some NPDs (e.g., response time variability measured by a computer task; Weyandt et al. 2018), it is unlikely that such a minor enhancement would translate into improved real-world academic performance (Evans et al., 2021).”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
In that prior study, performance was not examined across the three conditions.
“however, performance was not examined across the three conditions.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Ilieva et al., 2013 source
The Methods (Procedure and materials; page unavailable) describe a survey of perceived stimulant effects, and the Discussion explicitly asks how stimulant-enhanced motivation affects actual performance. This supports that the paper did not examine actual performance. It does not describe three conditions in its own study; the Introduction mentions three task/drug conditions only when discussing Volkow et al. (2004). (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
For college students with ADHD who have difficulties with attention and neuropsychological deficits due to dopamine deficits, stimulant medication helps by increasing dopamine to typical levels.
“For college students with ADHD who have difficulties with attention and neuropsychological deficits (NPDs; e.g., difficulties with EFs) due to dopamine deficits, stimulant medication helps these students by increasing dopamine to typical levels (Arnsten, 2006; Dela Peña et al., 2015; Willcutt, 2015).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Arnsten, 2006 source
- cites Dela Peña et al., 2015 source
The Introduction (section 2; page unavailable) says psychostimulants, including methylphenidate, increase brain dopamine levels and enhance dopamine transmission. It does not establish that college students with ADHD have dopamine deficits or that stimulant medication raises their dopamine to typical levels and thereby improves attention or executive-function difficulties. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Willcutt, 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Existing literature has demonstrated that individuals without ADHD engage in NPS partly due to perceived, non-cognitive enhancements in motivation.
“Existing literature has demonstrated that individuals without ADHD engage in NPS partly due to perceived, non-cognitive enhancements in motivation (Ilieva & Farah, 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Ilieva & Farah, 2013 source
- Findingown data
In college students without ADHD, there were no significant differences across baseline, placebo, and amphetamine-dextroamphetamine sessions for self-report/subjective neuropsychological measures and most objective measures.
“Results indicated no significant differences across sessions for self-report/subjective measures and most objective measures.”
Quote in the paperSubstantial claim - Findingown data
Participants reported minimal symptoms of IA (M = 1.14; SD = 1.49).
“reported minimal symptoms of IA (M = 1.14; SD = 1.49)”
Quote in the paperNot a substantial claim - Findingown data
All participants denied a lifetime diagnosis of ADHD.
“All participants denied a lifetime diagnosis of ADHD”
Quote in the paperSubstantial claim - Findingown data
There was not a significant main effect of time for CPT-IP omission errors (F = 2.28, p = 0.13, ηp2 = 0.10).
“omission errors (F = 2.28, p = 0.13, ηp2 = 0.10)”
Quote in the paperNot a substantial claim - Findingown data
There was not a significant main effect of time for SS-F total number of items answered correctly (F = 0.44, p = 0.64, ηp2 = 0.02).
“There was not a significant main effect of time for total number of items answered correctly for both the SS-F (F = 0.44, p = 0.64, ηp2 = 0.02)”
Quote in the paperNot a substantial claim - Findingown data
When controlling for capsule randomization, the main effect of time was no longer significant for CPT-IP d-prime (F = 0.12, p = 0.89, ηp2 = 0.01).
“When controlling for capsule randomization, however, the main effect of time was no longer significant for d-prime (F = 0.12, p = 0.89, ηp2 = 0.01)”
Quote in the paperSubstantial claim - Findingown data
For CPT-IP d-prime, performance for both amphetamine-dextroamphetamine and placebo conditions did not differ from one another.
“performance for both amphetamine–dextroamphetamine and placebo conditions did not differ from one another”
Quote in the paperSubstantial claim - Findingown data
When controlling for capsule randomization, the main effect of time was no longer significant for CPT-IP commission errors (F = 0.61, p = 0.55, ηp2 = 0.03).
“and commission errors (F = 0.61, p = 0.55, ηp2 = 0.03)”
Quote in the paperSubstantial claim - Findingown data
For CPT-IP d-prime, performance in both amphetamine-dextroamphetamine and placebo conditions was significantly improved compared to baseline.
“and were both significantly improved compared to baseline”
Quote in the paperNot a substantial claim - Findingown data
There was not a significant main effect of time for DSM-5 ADHD Symptoms Checklist IA severity (F = 0.87, p = 0.42, ηp2 = 0.04).
“There was not a significant main effect of time for IA severity (F = 0.87, p = 0.42, ηp2 = 0.04)”
Quote in the paperNot a substantial claim - Findingown data
There were no outcomes that demonstrated improvement only in the stimulant medication condition compared to the baseline and placebo conditions.
“there were no outcomes that demonstrated improvement only in the stimulant medication condition compared to the baseline and placebo conditions”
Quote in the paperSubstantial claim - Findingown data
There was not a significant main effect of time for CPT-IP response time variability (F = 0.76, p = 0.47, ηp2 = 0.04).
“There was not a significant main effect of time for response time variability (F = 0.76, p = 0.47, ηp2 = 0.04)”
Quote in the paperNot a substantial claim - Findingown data
There was not a significant main effect of time for BDEFS-SF-M total score (F = 1.16, p = 0.31, ηp2 = 0.06).
“There was not a significant main effect of time for total score (F = 1.16, p = 0.31, ηp2 = 0.06)”
Quote in the paperNot a substantial claim - Findingown data
There was a significant main effect of time for CPT-IP d-prime (F = 11.38, p < 0.01, ηp2 = 0.36).
“there was a significant main effect of time for d-prime (F = 11.38, p < 0.01, ηp2 = 0.36)”
Quote in the paperNot a substantial claim - Findingown data
Post hoc analyses demonstrated that improvements over time cannot be attributed entirely to order effects.
“Post hoc analyses, however, demonstrated that improvements over time cannot be attributed entirely to order effects.”
Quote in the paperSubstantial claim - Findingown data
Participants denied any history of NPS.
“Participants denied any history of NPS.”
Quote in the paperSubstantial claim - Findingown data
No post-baseline improvements were demonstrated for outcomes on self-report/subjective tasks.
“no post-baseline improvements were demonstrated for outcomes on self-report/subjective tasks”
Quote in the paperSubstantial claim - Findingown data
Post hoc analyses indicated a significant main effect of time for CPT-IP d-prime (F = 12.81, p < 0.01, ηp2 = 0.39).
“Post hoc analyses indicated a significant main effect of time for d-prime (F = 12.81, p < 0.01, ηp2 = 0.39)”
Quote in the paperNot a substantial claim - Findingown data
Post hoc analyses indicated a significant main effect of time for CPT-IP commission errors (F = 6.01, p < 0.01, ηp2 = 0.23).
“and commission errors (F = 6.01, p < 0.01, ηp2 = 0.23)”
Quote in the paperNot a substantial claim - Findingown data
Results for most outcomes for the objective tasks demonstrated no evidence of neuropsychological enhancement for any capsule condition when compared to the baseline condition.
“results for most outcomes for the objective tasks demonstrated no evidence of neuropsychological enhancement for any capsule condition when compared to the baseline condition”
Quote in the paperSubstantial claim - Findingown data
For CPT-IP commission errors, participants' performance improved when provided the placebo capsule compared to baseline.
“participants’ performance improved when provided the placebo capsule compared to baseline performance”
Quote in the paperNot a substantial claim - Findingown data
There was not a significant main effect of time for SS-B total number of items answered correctly (F = 1.00, p = 0.37, ηp2 = 0.05).
“and SS-B (F = 1.00, p = 0.37, ηp2 = 0.05)”
Quote in the paperNot a substantial claim - Findingown data
There was not a significant main effect of time for DSM-5 ADHD Symptoms Checklist HI severity (F = 0.01, p = 0.98, ηp2 = 0.00).
“and HI severity (F = 0.01, p = 0.98, ηp2 = 0.00)”
Quote in the paperNot a substantial claim - Findingown data
There were no significant differences between men and women on any outcome variables at baseline when using the Benjamini-Hochberg procedure to control for the false discovery rate.
“There were no significant differences between men and women on any outcome variables at baseline when using the Benjamini-Hochberg procedure to control for the false discovery rate.”
- Also stated in: § Discussion · plain
“Men and women did not differ on outcomes when controlling for the false discovery rate”
Quote in the paperNot a substantial claim - Also stated in: § Discussion · plain
- Findingown data
There was a significant main effect of time for CPT-IP commission errors (F = 5.51, p = 0.01, ηp2 = 0.22).
“There was also a significant main effect of time for commission errors (F = 5.51, p = 0.01, ηp2 = 0.22).”
Quote in the paperNot a substantial claim - Premisecitation
Students without ADHD may experience worsened attention and neuropsychological abilities from too much dopamine resulting from NPS.
“Students without ADHD may even experience worsened attention and neuropsychological abilities from too much dopamine that results from NPS (Mattay et al., 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mattay et al., 2000 source
- Premisereasoning
For those three between-subjects studies, analyses were underpowered to detect any differences (if present).
“For these studies, based on sample size and number of groups, analyses were underpowered to detect any differences (if present).”
Quote in the paperSubstantial claim - Premisereasoning
Without a baseline comparison condition, no prior studies have accounted for the potential impact on performance from ingesting a capsule, regardless of its contents.
“Without a baseline comparison condition, no studies have accounted for the potential impact on performance from ingesting a capsule, regardless of its contents.”
Quote in the paperNot a substantial claim - Premisenone given
Most of the six prior studies did not specify how participants were screened to ensure students with an ADHD diagnosis or greater severity of ADHD symptoms were excluded.
“Most studies did not specify how participants were screened to ensure students with an ADHD diagnosis or who reported greater severity of ADHD symptoms (which could indicate undiagnosed ADHD) were excluded.”
Quote in the paperSubstantial claim - Premisereasoning
No existing studies included self-report measures of NPDs to capture any changes (or lack thereof) from stimulant medication.
“Finally, no existing studies included self-report measures of NPDs to capture any changes (or lack thereof) from stimulant medication.”
Quote in the paperNot a substantial claim - Premisenone given
Objective computer tasks measure a limited number of NPDs in an artificial setting.
“Objective computer tasks measure a limited number of NPDs in an artificial setting.”
Quote in the paperNot a substantial claim - Interpretationown data
Perceived improvements in students without ADHD may be better attributed to placebo, rather than pharmacological, effects of a stimulant medication.
“perceived improvements may be better attributed to placebo, rather than pharmacological, effects of a stimulant medication for this group.”
Quote in the paperSubstantial claim - Study design and conductown data
For the current study, internal consistency for the BDEFS-SF-M total score across baseline, amphetamine-dextroamphetamine, and placebo sessions was acceptable to good (α = 0.79 - 0.88).
“For the current study, internal consistency for the BDEFS-SF-M total score across baseline, amphetamine–dextroamphetamine, and placebo sessions was acceptable to good (α = 0.79 – 0.88).”
Quote in the paperNot a substantial claim - Interpretationown data
Stimulant medication does not confer neuropsychological improvement in students without ADHD.
“Taken together, the results of this study provide further evidence that stimulant medication does not confer neuropsychological improvement in students without ADHD”
Quote in the paperSubstantial claim - Premisenone given
Three of the six prior studies administered 10 mg, 20 mg, or 40 mg of methylphenidate and used a between-subjects design.
“Three of the six studies administered 10 mg, 20 mg, or 40 mg of methylphenidate and used a between-subjects design.”
Quote in the paperSubstantial claim - Premisecitation
Self-report EF measures may more accurately measure behavioral manifestations of NPDs.
“In contrast, self-report EF measures may more accurately measure behavioral manifestations of NPDs (see Barkley, 2019 for more details).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Barkley, 2019 source
- Premisecitation
The selected 90-minute wait period allowed for the therapeutic effects of amphetamine-dextroamphetamine to occur before and throughout tasks.
“The selected 90-minute wait period for this study allowed for the therapeutic effects of amphetamine–dextroamphetamine to occur before and throughout tasks (Angrist et al., 1987).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Angrist et al., 1987 source
- Premisecitation
Individuals with ADHD who have more severe NPDs experience greater benefits from stimulant medication compared to individuals with ADHD who have less severe NPDs.
“Prior research has even demonstrated that individuals with ADHD who have more severe NPDs experience greater benefits from stimulant medication compared to individuals with ADHD who have less severe NPDs (Fosco et al., 2021; Nielsen et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Fosco et al., 2021
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Nielsen et al., 2017 source
- Study design and conductown data
The extent to which participants believed they received amphetamine-dextroamphetamine did not differ between the amphetamine-dextroamphetamine capsule session (M = 3.52, SD = 1.94) and the placebo capsule session (M = 2.38, SD = 1.88) (t = 1.76, p = 0.09).
“A paired-samples t-test indicated that the extent to which participants believed they received amphetamine–dextroamphetamine did not differ (t = 1.76, p = 0.09) between the amphetamine–dextroamphetamine capsule session (M = 3.52, SD = 1.94) and the placebo capsule session (M = 2.38, SD = 1.88).”
Quote in the paperSubstantial claim - Study design and conductreasoning
Analyses were powered to detect medium or large effects, so significant differences across sessions on an outcome with small effect sizes may have gone undetected.
“Finally, analyses were powered to detect medium or large effects. Although these effect sizes detect clinically meaningful enhancements, significant differences across sessions on an outcome with small effect sizes may have gone undetected.”
Quote in the paperNot a substantial claim - Interpretationcitation
Post-baseline improvements could be due to practice effects such that improvements occurred from task repetition and not the ingestion of a capsule regardless of its contents.
“these improvements could be due to practice effects (Calamia et al., 2012) such that improvements occurred from task repetition and not the ingestion of a capsule regardless of its contents”
- Also stated in: § Discussion · hedged
“Practice effects could explain post-baseline improvements despite post hoc analyses indicating improvement over time is significant beyond order effects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Calamia et al., 2012 source
- Also stated in: § Discussion · hedged
- Interpretationreasoning
Stimulant medication does not result in neuropsychological improvement among college students without ADHD.
“these results suggested that stimulant medication does not result in neuropsychological improvement among college students without ADHD”
Quote in the paperSubstantial claim - Interpretationown data
The hypothesis that college students without ADHD would neither perform better nor self-report improved neuropsychological functioning or attention when exposed to both stimulant medication and placebo conditions compared to baseline was supported across measures of subjective outcomes and most measures of objective outcomes.
“This hypothesis was supported across measures of subjective outcomes and most measures of objective outcomes.”
Quote in the paperSubstantial claim - Interpretationown data
These findings provide evidence against beliefs that NPS will enhance neuropsychological functioning among college students without ADHD.
“provide evidence against beliefs that NPS will enhance neuropsychological functioning among college students without ADHD”
Quote in the paperSubstantial claim - Interpretationown data
Any improvements may be due to receiving a capsule regardless of its contents.
“any improvements may be due to receiving a capsule regardless of its contents”
- Also stated in: § Discussion · hedged
“improvements may be due to a placebo effect from ingesting a capsule and not from the contents of the capsule”
Quote in the paperSubstantial claim - Also stated in: § Discussion · hedged
- Classified as probably not a substantial claim. 32
- May combine two claims. 13
- The quote only partly states this claim. 2
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationTest-retest reliability for Spatial Span total items correct was moderate (intraclass correlation coefficient = 0.67) in samples without ADHD.
“Test-retest reliability for total items correct was moderate (intraclass correlation coefficient = 0.67) in samples without ADHD (Woods et al., 2016).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Woods et al., 2016 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther studies examining the effects of stimulant medication using neuropsychological measures have also used this waiting period length.
“Other studies examining the effects of stimulant medication using neuropsychological measures have also used this waiting period length (e.g., Batistela et al., 2016).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Batistela et al., 2016 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNPS is especially prevalent during emerging adulthood, particularly among college students compared to peers who do not attend college.
“NPS becomes especially prevalent during emerging adulthood, particularly among college students when compared to their peers who do not attend college (McCabe et al., 2018; Schepis et al., 2020).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites McCabe et al., 2018 source
- cites Schepis et al., 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSimilar screening criteria have been used by other studies.
“Similar screening criteria have been used by other studies (e.g., Ilieva et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Ilieva et al., 2013 source
May combine two claims.
PremisecitationSix prior studies have largely found no evidence of meaningful neuropsychological improvement in students without ADHD who ingest a stimulant medication, including no improvements for working memory, response inhibition, vigilance, cognitive processing speed, planning, set-shifting, interference control, and distraction suppression.
“Six studies have largely found no evidence of meaningful neuropsychological improvement in students without ADHD who ingest a stimulant medication.”
- Also stated in: § Abstract · boosted
“These studies demonstrated no improvements from stimulant medication for NPDs including working memory, response inhibition, vigilance, cognitive processing speed, planning, set-shifting, interference control, and distraction suppression (Batistela et al., 2016; Bray et al., 2004; Cropsey et al., 2017; Ilieva et al., 2013; Mommaerts et al., 2013; Weyandt et al., 2018).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Batistela et al., 2016 source
The Discussion reports no effect of methylphenidate on cognitive functioning in this study of healthy young people, and it describes another study with no improvement in attention or working memory. It does not establish the citing sentence’s count of six studies; it also reports improvements in visuo-spatial memory and planning in one prior study. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Bray et al., 2004 source
- cites Cropsey et al., 2017 source
- Also stated in: § Abstract · boosted
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlternative strategies, such as spaced practice and sufficient sleep, are likely to have a greater impact on academic performance for students.
“alternative strategies, such as spaced practice and sufficient sleep, are likely to have a greater impact on academic performance for students (e.g., Cepeda et al., 2006, Okano et al, 2019).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Cepeda et al., 2006 source
The Educational Implications section (p. 14) says spaced learning improves long-term retention compared with concentrating study in one session, including in studies of children. Cepeda et al. do not establish its comparative impact on students’ overall academic performance; sufficient sleep is associated with the other citation, not this one. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites Okano et al, 2019 source
The Discussion reports that longer, better-quality, more consistent sleep was associated with better academic performance. But it says a causal effect requires randomized trials, so the claim that sufficient sleep is likely to have a greater impact is stronger than this study establishes. Spaced practice is attributed to the other citation, not Okano et al. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants reported minimal symptoms of HI (M = 0.67; SD = 0.91).
“HI (M = 0.67; SD = 0.91)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor two outcomes on the Continuous Performance Task - Identical Pairs, performance improved either in both the stimulant and placebo conditions compared to baseline or in the placebo condition compared to baseline.
“Specifically, for two outcomes on an objective measure (i.e., Continuous Performance Task - Identical Pairs), performance improved in either both the stimulant and placebo conditions compared to baseline or the placebo condition compared to baseline.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataImprovement occurred in the placebo or placebo and stimulant medication conditions compared to baseline for two outcomes on an objective task.
“This occurred for two outcomes on an objective task.”
- Also stated in: § Discussion · plain
“improvements occurred for 2 of 6 outcomes on objective tasks”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataParticipants reported consistently receiving adequate sleep on the night before each of the laboratory sessions (M = 6.79 - 7.02).
“Participants reported consistently receiving adequate sleep on the night before each of the laboratory sessions (M = 6.79 – 7.02).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataScores on the IUQ indicated a minimal likelihood for participants at the present time to misuse a stimulant medication to aid with studying or improving academic performance (M = 1.81; range: 0 - 13 out of 100).
“Scores on the IUQ indicated a minimal likelihood for participants at the present time to misuse a stimulant medication to aid with studying or improving academic performance (M = 1.81; range: 0 – 13 out of 100)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataScores on the IUQ indicated a minimal likelihood for participants at the present time to misuse a stimulant medication to party or get high (M = 0.19; range: 0 - 1 out of 100).
“or to party or get high (M = 0.19; range: 0 – 1 out of 100)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
PremisereasoningSelf-report measures that assess behavioral manifestations of NPDs such as time management can provide a more comprehensive understanding of the effects of stimulant medication on NPDs.
“The use of self-report measures that assess behavioral manifestations of NPDs such as time management can provide a more comprehensive understanding of the effects of stimulant medication on NPDs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningThe remaining three of the six prior studies administered 10 mg, 20 mg, or 30 mg of mixed amphetamine salts and used a within-subjects design.
“The remaining three out of the six studies administered 10 mg, 20 mg, or 30 mg of mixed amphetamine salts (formulations were not described) and used a within-subjects design.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe CPT-IP has demonstrated good test-retest reliability for d-prime (r = 0.81) and acceptable test-retest reliability for mean reaction time (r = 0.74) in samples without ADHD.
“The CPT-IP has demonstrated good test-retest reliability for d-prime (r = 0.81) and acceptable test-retest reliability for mean reaction time (r = 0.74) in samples without ADHD (Hahn et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hahn et al., 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThis study was preregistered.
“This study was preregistered; see https://clinicaltrials.gov/study/NCT03935646.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenCategorization as low risk was monitored and verified throughout the study.
“Categorization as low risk was monitored and verified throughout the study.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenThe two experimental sessions were double-blinded and counterbalanced.
“The two experimental sessions were double-blinded and counterbalanced.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted). May combine two claims.
PremisecitationThere is a firmly held belief that stimulant medication improves executive functions and academic skills while decreasing distractibility, restlessness, fatigue, and sleepiness.
“There is a firmly held belief that stimulant medication improves executive functions (EFs; e.g., sustained attention, working memory) and academic skills (e.g., reading comprehension, productivity) while decreasing distractibility, restlessness, fatigue, and sleepiness (Benson et al., 2015; DeSantis et al., 2008; Hartung et al., 2013; Rabiner et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenParticipants who completed all study sessions were included in analyses.
“Participants who completed all study sessions were included in analyses.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCollege students without ADHD are likely to experience little to no benefit from taking stimulant medication because there is no dopamine deficit to correct.
“College students without ADHD, however, are likely to experience little to no benefit from taking stimulant medication because there is no dopamine deficit to correct (e.g., Cropsey et al., 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cropsey et al., 2017 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAdequate sample size was determined using a power analysis.
“Adequate sample size was determined using a power analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe Benjamini-Hochberg procedure was used to control for the false discovery rate in exploratory analyses.
“The Benjamini-Hochberg (BH) procedure was used to control for the false discovery rate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
PremisereasoningSelf-report measures of behavioral manifestations of NPDs are more ecologically valid and may provide a convincing argument to students that NPS does not improve NPDs most relevant to behavioral changes that could result in academic enhancement.
“Additionally, these types of measures are more ecologically valid and may provide a convincing argument to students that NPS does not improve NPDs most relevant to behavioral changes that could result in academic enhancement.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThere were no adverse reactions to any administered capsules and no unexpected in-lab emergencies.
“There were no adverse reactions to any administered capsules and no unexpected in-lab emergencies.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe final sample of 21 had high power (1 - β = 0.88) to detect a medium effect (f = 0.25) and high power (1 - β = 0.99) to detect a large effect (f = 0.40).
“The final sample of 21 had high power (1 - β = 0.88) to detect a medium effect (f = 0.25) and high power (1- β = 0.99) to detect a large effect (f = 0.40).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Faul et al., 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe CONSORT reporting guidelines were used to present data from this study.
“The CONSORT reporting guidelines (Schulz et al. 2010) were used to present data from this study (see Figure 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schulz et al. 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther studies have observed self-reported EF changes resulting from stimulant medication use among college students with ADHD.
“Although no studies have used the BDEFS-SF-M, other studies (e.g., DuPaul et al., 2012) have observed self-reported EF changes resulting from stimulant medication use among college students with ADHD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DuPaul et al., 2012 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenParticipants categorized as low risk for amphetamine-dextroamphetamine use were included in the study.
“Participants categorized as low risk for amphetamine–dextroamphetamine use were included in the study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAcross these three within-subjects studies, participants held positive beliefs about receiving stimulant medication.
“Across these three studies, participants held positive beliefs about receiving stimulant medication.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningBoth types of capsules were visibly indistinguishable.
“Both types of capsules were visibly indistinguishable.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFor the current study, internal consistency was good for the IA subscale (α = 0.85) and questionable for the HI subscale (α = 0.67) on the DSM-5 ADHD Symptoms Checklist.
“For the current study, internal consistency was good for the IA subscale (α = 0.85) and questionable for the HI subscale (α = 0.67).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenConsumption of caffeine was not monitored between sessions, although participants abstained from caffeine for at least 12 hours prior to each session.
“Consumption of caffeine (e.g., coffee, tea) was not monitored between sessions, although participants abstained from caffeine for at least 12 hours prior to each session.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCollege students have particularly strong beliefs about neuropsychological enhancement from NPS, especially in improving academic performance.
“College students have particularly strong beliefs about neuropsychological enhancement from NPS, especially in improving academic performance (e.g., Benson et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Benson et al., 2015 source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationPost-baseline improvements for some outcomes may also be due to increases in motivation from receiving a capsule.
“Post-baseline improvements for some outcomes may also be due to increases in motivation from receiving a capsule.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Interpretationnone givenThere are other factors unrelated to the study that may have influenced how participants responded to self-report/subjective measures completed at least 24 hours after the start of sessions.
“there are other factors unrelated to the study that may have influenced how participants responded”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationown dataBecause only amphetamine-dextroamphetamine IR 10 mg was administered, results do not necessarily apply to other dosages, formulations (i.e., extended-release), or varieties of stimulant medication, or account for individual variations of usage or side effects.
“Because only amphetamine–dextroamphetamine IR 10 mg was administered in the current study, results do not necessarily apply to other dosages, formulations (i.e., extended-release), or varieties of stimulant medication, or account for individual variations of usage (e.g., taking multiple doses in a 24-hour period) or side effects.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMeals prior to each session were not standardized, potentially varying the rate and extent of stimulant absorption.
“Meals prior to each session were not standardized, potentially varying the rate and extent of stimulant absorption.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
College students cite cognitive enhancement, specifically academic improvement, as the most common reason for NPS.
“College students cite cognitive enhancement, specifically academic improvement, as the most common reason for NPS.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Discussion claims improvement beyond order effects despite nonsignificant adjusted results
MajorThe discussion says the post hoc analyses showed improvement over time beyond order effects. The reported main effects of time were no longer significant after controlling for capsule randomization (p = 0.89 and p = 0.55), so those analyses do not support that claim.
“Post hoc analyses, however, demonstrated that improvements over time cannot be attributed entirely to order effects.”
“When controlling for capsule randomization, however, the main effect of time was no longer significant for d-prime (F = 0.12, p = 0.89, ηp2 = 0.01) and commission errors (F = 0.61, p = 0.55, ηp2 = 0.03).”
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 3
- Barkley RA (2011). Barkley Adult ADHD Rating Scale-IV (BAARS-IV). New York, NY: Guilford Press.
- Preuss CV, Kalava A, & King KC (2024). Prescription of Controlled Substances: Benefits and Risks. In StatPearls. StatPearls Publishing. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK537318/
- Willcutt EG (2015). Theories of ADHD. In Barkley RA (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (4th ed., pp. 391– 404). The Guilford Press.
- Authors
- Vasko, J. M., Looby, A., Serrano, J. W., Abu-Ramadan, T. M., Miller, E. A., McGee, N., Smith, D. T., & Hartung, C. M.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- University of Wyoming (US)
- University of Denver (US)
- Children's National (US)
- ORCID
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2026-08
- Volume
- 34
- Issue
- 4
- Pages
- 426-434
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- PMC
- PMC13166096
- OpenAlex
- W7160869862
- Cited by
- 0
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Experimental and Clinical Psychopharmacology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (2P20GM103432)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- stimulant medication, placebo effect, university students, neuropsychological performance, continuous performance test
- MeSH terms
- Cognitive Enhancement, Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Dextroamphetamine, Female, Humans, Male, Neuropsychological Tests, Students, Universities, Young Adult, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review